CO5050294A1 - NEW INDOLINONES REPLACED, THEIR PREPARATION AND THEIR EMPLOYMENT AS MEDICINES - Google Patents
NEW INDOLINONES REPLACED, THEIR PREPARATION AND THEIR EMPLOYMENT AS MEDICINESInfo
- Publication number
- CO5050294A1 CO5050294A1 CO99035396A CO99035396A CO5050294A1 CO 5050294 A1 CO5050294 A1 CO 5050294A1 CO 99035396 A CO99035396 A CO 99035396A CO 99035396 A CO99035396 A CO 99035396A CO 5050294 A1 CO5050294 A1 CO 5050294A1
- Authority
- CO
- Colombia
- Prior art keywords
- group
- alkyl
- amino
- substituted
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
Abstract
Indolinonas sustituidas de la fórmula generalen la queX significa un átomo de oxígeno o azufreR1 significa un átomo de hidrógeno, un grupo alcoxi C1-4 AND#150;carbonilo o alcanoílo C2-4 , R2 significa un grupo carboxi o alcoxi C1-4 AND#150;carbonilo, o un grupo aminocarbonilo eventualmente sustituido con uno o dos grupos alquilo C1-3 , en donde los sustituyentes pueden ser iguales o diferentes,R3 significa un átomo de hidrógeno o un grupo alquilo C1-6 que, a partir de la posición 2 referida al átomo de carbono del grupo R3 AND#150;C(R4 NR5 )=, puede estar sustituido con un átomo de flúor, cloro o bromo, con un grupo hidroxi, alcoxi C1-3 , alquil C1-3 AND#150;sulfenilo, alquil C1-3 AND#150;sulfinilo, alquil C1-3 AND#150;sulfonilo, fenilsulfenilo, fenilsulfinilo, amino, alquil C1-3 AND#150;amino, di-(alquil C1-3 )-amino, alcanoil C2-5 AND#150;amino o N-(alquil C1-3 AND#150; amino)-alcanoil C2-5 AND#150;amino,R4 significa un átomo de hidrógeno, un grupo alquilo C1-6 o un grupo cicloalquilo C5-7 eventualmente sustituido con un grupo alquilo C1-3 , en el que un grupo metilo en la posición 3 ó 4 referida al átomo de carbono del grupo R3 AND#150;C(R4 NR5 )=, puede estar sustituido con un grupo imino eventualmente sustituido con un grupo alquilo C1-3 ,un grupo fenilo o naftilo, que puede estar sustituido con un átomo de flúor, cloro, bromo o yodo,con un grupo metoxi, eventualmente sustituido con 1 a 3 átomos de flúor,con un grupo alcoxi C2-3 que, en posición 2 ó 3, puede estar sustituido con un grupo alquil C1-3 AND#150; amino, di-(alquil C1-3 )-amino o cicloalquilenimino de 5 a 7 miembros, en donde, en cada caso, adicionalmente una parte de alquilo en los grupos alquilamino y dialquilamino precedente mencionados puede estar sustituida con un grupo fenilo,con un grupo trifluorometilo, amino, alquil C1-3 AND#150; amino, di-(alquil C1-3 )-amino, alcanoil C2-5 AND#150;amino, - 2 -N-(alquil C1-3 )-alcanoil C2-5 AND#150;amino, alquil C1-5 AND#150; sulfonilamino, N-(alquil C1-3 )-alquil C1-5 AND#150; sulfonilamino, fenilsulfonilamino, N-alquil C1-3 )-fenilsulfonilamino, aminosulfonilo, alquil C1-3 AND#150; amino-sulfonilo o di-(alquil C1-3 )-aminosulfonilo, en donde, en cada caso, adicionalmente una parte de alquilo en los grupos alquilamino y dialquilamino precedentemente mencionados puede estar sustituida con un grupo fenilo,con un grupo carbonilo, que está sustituido con un grupo hidroxi, alcoxi C1-3 , amino, alquil C1-3 AND#150;amino o N-(alquil C1-5 )-alquil C1-3 AND#150;amino, en donde, en cada caso, adicionalmente una parte de alquilo en los grupos precedentemente mencionados puede estar sustituida con un grupo carboxi, alcoxi C1-3 AND#150; carbonilo o fenilo o, en posición 2 ó 3, con un grupo di-(alquil C1-3 )-amino, piperazino, N-(alquil C1-3 )-piperazino o cicloalquilenimino de 5 a 7 miembros, con un grupo alquilo C1-3 , que está sustituido con un grupo amino, alquil C1-7 AND#150;amino, cicloalquil C5-7 AND#150;amino o fenil-alquil C1-3 AND#150;amino, que en cada caso puede estar sustituido adicionalmente en el átomo de nitrógeno con un grupo alquilo C1-3 , en el que los átomos de hidrógeno están reemplazados, parcial o totalmente, por átomos de flúor, con un grupo cicloalquilo C5-7 , alquenilo C2-4 o alquilo C1-4 en donde el sustituyente alquilo C1-4 precedentemente mencionado puede estar sustituido en cada caso adicionalmente con un grupo ciano, carboxi, alcoxi C1-3 -carbonilo, piridilo, imidazolilo, benzo[1,3]dioxol o fenilo, pudiendo estar el grupo fenilo mono-, di- o tri-sustituido con átomos de flúor, cloro o bromo, con un grupo metilo, metoxi, trifluorometilo, ciano o nitro, y los sustituyentes pueden ser iguales o diferentes, o puede estar sustituido en posición 2, 3 ó 4 con un grupo hidroxi,con un grupo alquilo C1-3 que puede estar sustituido con un grupo hidroxi, carboxi, tiomorfolino, 1-óxido-tiomorfolino, 1,1-dióxido-tiomorfolino, piperazino, N-(alquil C1-3 )-piperazino o N-fenil-piperazino, con un grupo cicloalquilenimino de 5 a 7 miembros o con un grupo cicloalquilenimino de 4 a 7 miembros, en donde los grupos cicloalquilenimino de 5 a 7 miembros precedentemente mencionados pueden estar sustituidos con uno o dos grupos alquilo C1-3 , con un grupo cicloalquilo C5-7 o fenilo, con un grupo alquilo C1-3 , cicloalquilo C5-7 , fenilo carboxi o alcoxi C1-4 -carbonilo y con un grupo hidroxi, y en los grupos cicloalquilenimino precedentemente mencionados un grupo metileno contiguo al átomo de nitrógeno puede estar reemplazado por un grupo carbonilocon un grupo alquilo C 1-3 , que está sustituido con un grupo cicloalquilenimino de 5 a 7 miembros, estando condensado a los grupos cicloalquilenimino de 5 a 7 miembros precedentemente mencionados, a través de 2 átomos de carbono continuos, un grupo fenilo eventualmente mono- o di-sustituido con átomos de flúor cloro o bromo, con grupos metilo o metoxi, pudiendo ser los sustituyentes iguales o diferentes, o un grupo oxazolo, imidazolo, tiazolo, piridino, pirazino o pirimidino eventualmente sustituido con un grupo metilo, metoxi o amino, pudiendo estar sustituido adicionalmente los grupos fenilo monosustituidos, precedentemente mencionados, con un átomo de flúor, cloro o bromo, con un grupo metilo, metoxi o nitro, un grupo heteroaromático de 5 miembros, que contiene un grupo imino, un átomo de oxígeno o azufre, o un grupo imino, un átomo de oxígeno o azufre y uno o dos átomos de nitrógeno, o un grupo heteroaromático de 6 miembros, que contiene uno, dos o tres átomos de nitrógeno, en donde los grupos heteroaromáticos de 5 y 6 miembros precedentemente mencionados pueden estar sustituidos adicionalmente con un átomo de cloro bromo o con un grupo metilo, o a los grupos heteroaromáticos de 5 a 6 miembros precedentemente mencionados puede estar condensado un anillo de fenilo a través de 2 átomos de carbono contiguos, yR5 significa un átomo de hidrógeno o un grupo alquilo C1-3 , pudiendo estar sustituidos los grupos carboxi, amino o imino presentes con radicales separables in vivo,sus isómeros y sus sales.Substituted indolinones of the formula generally where X means an oxygen or sulfur atom R1 means a hydrogen atom, a C1-4 AND # 150 alkoxy group; C2-4 carbonyl or alkanoyl, R2 means a carboxy or C1-4 AND # alkoxy group 150; carbonyl, or an aminocarbonyl group optionally substituted with one or two C1-3 alkyl groups, wherein the substituents may be the same or different, R3 means a hydrogen atom or a C1-6 alkyl group which, from the position 2 referred to the carbon atom of the group R3 AND # 150; C (R4 NR5) =, may be substituted with a fluorine, chlorine or bromine atom, with a hydroxy group, C1-3 alkoxy, C1-3 alkyl AND # 150 ; sulfenyl, C1-3 alkyl # 150; sulfinyl, C1-3 alkyl AND # 150; sulfonyl, phenylsulfenyl, phenylsulfinyl, amino, C1-3 alkyl AND # 150; amino, di- (C1-3 alkyl) -amino, C2-5 alkanoyl AND # 150; amino or N- (C1-3 alkyl AND # 150; amino) -C2-5 alkanoyl AND # 150; amino, R4 means a hydrogen atom, a C1-6 alkyl group or a gru po C5-7 cycloalkyl optionally substituted with a C1-3 alkyl group, in which a methyl group in position 3 or 4 referred to the carbon atom of the group R3 AND # 150; C (R4 NR5) =, may be substituted with an imino group optionally substituted with a C1-3 alkyl group, a phenyl or naphthyl group, which may be substituted with a fluorine, chlorine, bromine or iodine atom, with a methoxy group, optionally substituted with 1 to 3 fluorine atoms, with a C2-3 alkoxy group which, in position 2 or 3, may be substituted with a C1-3 alkyl group AND # 150; amino, di- (C1-3 alkyl) -amino or cycloalkyleneimino of 5 to 7 members, wherein, in each case, additionally a part of alkyl in the aforementioned alkylamino and dialkylamino groups may be substituted with a phenyl group, with a trifluoromethyl group, amino, C1-3 alkyl AND # 150; amino, di- (C1-3 alkyl) -amino, C2-5 alkanoyl AND # 150; amino, - 2 -N- (C1-3 alkyl) -C2-5 alkanoyl AND # 150; amino, C1-5 AND alkyl # 150; sulfonylamino, N- (C1-3 alkyl) -C1-5 alkyl AND # 150; sulfonylamino, phenylsulfonylamino, N-C1-3 alkyl) -phenylsulfonylamino, aminosulfonyl, C1-3 alkyl AND # 150; amino-sulfonyl or di- (C1-3-alkyl) -aminosulfonyl, wherein, in each case, additionally a part of alkyl in the aforementioned alkylamino and dialkylamino groups may be substituted with a phenyl group, with a carbonyl group, which is substituted with a hydroxy group, C1-3 alkoxy, amino, C1-3 alkyl AND # 150; amino or N- (C1-5 alkyl) -C1-3 alkyl AND # 150; amino, where, in each case, additionally an alkyl part in the aforementioned groups may be substituted with a carboxy group, C1-3 alkoxy AND # 150; carbonyl or phenyl or, in position 2 or 3, with a di- (C1-3 alkyl) -amino, piperazino, N- (C1-3 alkyl) -piperazino or cycloalkyleneimino group of 5 to 7 members, with a C1-alkyl group -3, which is substituted with an amino group, C1-7 alkyl AND # 150; amino, C5-7 cycloalkyl AND # 150; amino or phenyl-C1-3 alkyl AND # 150; amino, which in each case may be substituted additionally in the nitrogen atom with a C1-3 alkyl group, in which the hydrogen atoms are partially or totally replaced by fluorine atoms, with a C5-7 cycloalkyl, C2-4 alkenyl or C1-4 alkyl group wherein the above-mentioned C1-4 alkyl substituent may be additionally substituted in each case with a cyano, carboxy, C1-3 alkoxycarbonyl, pyridyl, imidazolyl, benzo [1,3] dioxol or phenyl group, the phenyl group may be mono-, di- or tri-substituted with fluorine, chlorine or bromine atoms, with a methyl, methoxy, trifluoromethyl, cyano or nitro group, and the substituents can n be the same or different, or it may be substituted in position 2, 3 or 4 with a hydroxy group, with a C1-3 alkyl group which may be substituted with a hydroxy, carboxy, thiomorpholino, 1-oxide-thiomorpholino group, 1, 1-Dioxide-thiomorpholino, piperazino, N- (C1-3 alkyl) -piperazino or N-phenyl-piperazino, with a cycloalkyleneimino group of 5 to 7 members or with a cycloalkyleneimino group of 4 to 7 members, wherein cycloalkyleneimino groups 5 to 7 members mentioned above may be substituted with one or two C1-3 alkyl groups, with a C5-7 cycloalkyl or phenyl group, with a C1-3 alkyl, C5-7 cycloalkyl, carboxy phenyl or C1-4 alkoxy group -carbonyl and with a hydroxy group, and in the aforementioned cycloalkyleneimino groups a methylene group contiguous with the nitrogen atom may be replaced by a carbonyl group with a C 1-3 alkyl group, which is substituted with a 5 to 7 membered cycloalkyleneimino group , being condensed to the group s 5 to 7 cycloalkyleneimino mentioned above, through 2 continuous carbon atoms, a phenyl group optionally mono- or di-substituted with chlorine or bromine fluorine atoms, with methyl or methoxy groups, the substituents being the same or different , or an oxazolo, imidazolo, thiazolo, pyridino, pyrazino or pyrimidino group optionally substituted with a methyl, methoxy or amino group, the monosubstituted phenyl groups, mentioned above, being additionally substituted with a fluorine, chlorine or bromine atom, with a methyl, methoxy or nitro group, a 5-membered heteroaromatic group, which contains an imino group, an oxygen or sulfur atom, or an imino group, an oxygen or sulfur atom and one or two nitrogen atoms, or a heteroaromatic group 6-member, containing one, two or three nitrogen atoms, wherein the aforementioned 5 and 6 member heteroaromatic groups may be additionally substituted With a bromine chlorine atom or with a methyl group, or to the above mentioned 5 to 6 member heteroaromatic groups, a phenyl ring may be condensed through 2 contiguous carbon atoms, and R5 means a hydrogen atom or an alkyl group C1-3, the carboxy, amino or imino groups present with separable radicals in vivo, their isomers and their salts may be substituted.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19824922A DE19824922A1 (en) | 1998-06-04 | 1998-06-04 | Novel substituted indolinones, their preparation and their use as pharmaceuticals |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5050294A1 true CO5050294A1 (en) | 2001-06-27 |
Family
ID=7869856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO99035396A CO5050294A1 (en) | 1998-06-04 | 1999-06-04 | NEW INDOLINONES REPLACED, THEIR PREPARATION AND THEIR EMPLOYMENT AS MEDICINES |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP1100779A1 (en) |
JP (1) | JP2002516906A (en) |
KR (1) | KR20010043973A (en) |
CN (1) | CN1303374A (en) |
AU (1) | AU764782B2 (en) |
BG (1) | BG104938A (en) |
BR (1) | BR9910898A (en) |
CA (1) | CA2328291A1 (en) |
CO (1) | CO5050294A1 (en) |
DE (1) | DE19824922A1 (en) |
EA (1) | EA003514B1 (en) |
EE (1) | EE200000723A (en) |
HR (1) | HRP20000831A2 (en) |
HU (1) | HUP0102210A3 (en) |
ID (1) | ID27035A (en) |
IL (1) | IL138702A0 (en) |
NO (1) | NO20006138L (en) |
PL (1) | PL344467A1 (en) |
SK (1) | SK18222000A3 (en) |
TR (1) | TR200003515T2 (en) |
WO (1) | WO1999062882A1 (en) |
YU (1) | YU73900A (en) |
ZA (1) | ZA200005435B (en) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19816624A1 (en) * | 1998-04-15 | 1999-10-21 | Boehringer Ingelheim Pharma | Novel substituted indolinones, their preparation and their use as pharmaceuticals |
GB9904933D0 (en) * | 1999-03-04 | 1999-04-28 | Glaxo Group Ltd | Compounds |
US6624171B1 (en) | 1999-03-04 | 2003-09-23 | Smithkline Beecham Corporation | Substituted aza-oxindole derivatives |
US6762180B1 (en) | 1999-10-13 | 2004-07-13 | Boehringer Ingelheim Pharma Kg | Substituted indolines which inhibit receptor tyrosine kinases |
UA75054C2 (en) | 1999-10-13 | 2006-03-15 | Бьорінгер Інгельхайм Фарма Гмбх & Ко. Кг | Substituted in position 6 indolinones, producing and use thereof as medicament |
JP2004508366A (en) * | 2000-09-01 | 2004-03-18 | グラクソ グループ リミテッド | Oxindole derivatives |
AU2001288374A1 (en) | 2000-09-01 | 2002-03-22 | Glaxo Group Limited | Substituted oxindole derivatives as tyrosine kinase inhibitors |
DE10117204A1 (en) * | 2001-04-06 | 2002-10-10 | Boehringer Ingelheim Pharma | Indolinones substituted in the 6-position, their preparation and their use as medicaments |
JP2004537537A (en) * | 2001-06-29 | 2004-12-16 | アブ サイエンス | Uses of tyrosine kinase inhibitors to treat inflammatory diseases |
US7700610B2 (en) | 2001-06-29 | 2010-04-20 | Ab Science | Use of tyrosine kinase inhibitors for treating allergic diseases |
JP2004536097A (en) * | 2001-06-29 | 2004-12-02 | アブ サイエンス | Uses of tyrosine kinase inhibitors to treat autoimmune diseases |
US7678805B2 (en) | 2001-06-29 | 2010-03-16 | Ab Science | Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (IBD) |
ATE376182T1 (en) | 2001-06-29 | 2007-11-15 | Ab Science | C-KIT INHIBITORS |
US6765012B2 (en) | 2001-09-27 | 2004-07-20 | Allergan, Inc. | 3-(Arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
US7169936B2 (en) | 2002-07-23 | 2007-01-30 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments |
JP4879492B2 (en) * | 2002-11-27 | 2012-02-22 | アラーガン、インコーポレイテッド | Kinase inhibitors for the treatment of diseases |
DE102004012070A1 (en) * | 2004-03-12 | 2005-09-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New cycloalkyl-containing 5-acylindolinones, their preparation and their use as medicaments |
PE20060777A1 (en) * | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | INDOLINONE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES |
CN101547892B (en) * | 2006-12-05 | 2014-08-20 | 艾尼纳制药公司 | Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof |
GB0706072D0 (en) * | 2007-03-28 | 2007-05-09 | Sterix Ltd | Compound |
US20170065529A1 (en) | 2015-09-09 | 2017-03-09 | Boehringer Ingelheim International Gmbh | Pharmaceutical dosage form for immediate release of an indolinone derivative |
CN101735071A (en) * | 2009-12-04 | 2010-06-16 | 大连凯飞精细化工有限公司 | Method for producing 4-N,N-dimethylamino methylaniline |
CN103102352B (en) * | 2011-11-15 | 2015-08-12 | 山东亨利医药科技有限责任公司 | Tyrosine kinase inhibitor indolinone derivative |
CN103130775B (en) * | 2011-11-22 | 2015-09-30 | 山东亨利医药科技有限责任公司 | As the dihydroindole ketone derivate of tyrosine kinase inhibitor |
GB201208775D0 (en) | 2012-05-18 | 2012-07-04 | Uni I Oslo | Chemical compounds |
CN103848814B (en) * | 2012-12-06 | 2016-08-17 | 山东亨利医药科技有限责任公司 | The full ketone derivatives of substituted indole as tyrosine kinase inhibitor |
WO2024050297A1 (en) * | 2022-09-02 | 2024-03-07 | Deciphera Pharmaceuticals, Llc | Ulk inhibitors and methods of use thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE838623A (en) * | 1976-02-16 | 1976-06-16 | 3-HYDROXYMETHYLENE-2-INDOLINONE DERIVATIVES AND PROCESS FOR THEIR PRODUCTION | |
US4145422A (en) * | 1977-09-06 | 1979-03-20 | Abbott Laboratories | Aminomethylene oxindoles |
US5880141A (en) * | 1995-06-07 | 1999-03-09 | Sugen, Inc. | Benzylidene-Z-indoline compounds for the treatment of disease |
AU4155697A (en) * | 1996-08-23 | 1998-03-06 | Sugen, Inc. | Indolinone combinatorial libraries and related products and methods for the treatment of disease |
GB9718913D0 (en) * | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Substituted oxindole derivatives |
-
1998
- 1998-06-04 DE DE19824922A patent/DE19824922A1/en not_active Withdrawn
-
1999
- 1999-05-28 IL IL13870299A patent/IL138702A0/en unknown
- 1999-05-28 AU AU43707/99A patent/AU764782B2/en not_active Ceased
- 1999-05-28 ID IDW20002523A patent/ID27035A/en unknown
- 1999-05-28 EP EP99926454A patent/EP1100779A1/en not_active Withdrawn
- 1999-05-28 KR KR1020007013597A patent/KR20010043973A/en not_active Application Discontinuation
- 1999-05-28 SK SK1822-2000A patent/SK18222000A3/en unknown
- 1999-05-28 EE EEP200000723A patent/EE200000723A/en unknown
- 1999-05-28 WO PCT/EP1999/003692 patent/WO1999062882A1/en not_active Application Discontinuation
- 1999-05-28 TR TR2000/03515T patent/TR200003515T2/en unknown
- 1999-05-28 JP JP2000552094A patent/JP2002516906A/en active Pending
- 1999-05-28 YU YU73900A patent/YU73900A/en unknown
- 1999-05-28 HU HU0102210A patent/HUP0102210A3/en unknown
- 1999-05-28 BR BR9910898-4A patent/BR9910898A/en not_active IP Right Cessation
- 1999-05-28 EA EA200100001A patent/EA003514B1/en not_active IP Right Cessation
- 1999-05-28 CA CA002328291A patent/CA2328291A1/en not_active Abandoned
- 1999-05-28 PL PL99344467A patent/PL344467A1/en unknown
- 1999-05-28 CN CN99806884A patent/CN1303374A/en active Pending
- 1999-06-04 CO CO99035396A patent/CO5050294A1/en unknown
-
2000
- 2000-10-05 ZA ZA200005435A patent/ZA200005435B/en unknown
- 2000-11-13 BG BG104938A patent/BG104938A/en active Pending
- 2000-12-01 NO NO20006138A patent/NO20006138L/en not_active Application Discontinuation
- 2000-12-01 HR HR20000831A patent/HRP20000831A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TR200003515T2 (en) | 2001-06-21 |
NO20006138L (en) | 2001-02-01 |
CN1303374A (en) | 2001-07-11 |
JP2002516906A (en) | 2002-06-11 |
IL138702A0 (en) | 2001-10-31 |
ZA200005435B (en) | 2002-01-07 |
HRP20000831A2 (en) | 2001-12-31 |
CA2328291A1 (en) | 1999-12-09 |
EA003514B1 (en) | 2003-06-26 |
ID27035A (en) | 2001-02-22 |
EE200000723A (en) | 2002-04-15 |
EP1100779A1 (en) | 2001-05-23 |
AU4370799A (en) | 1999-12-20 |
YU73900A (en) | 2003-04-30 |
HUP0102210A2 (en) | 2001-11-28 |
BR9910898A (en) | 2001-02-13 |
SK18222000A3 (en) | 2001-08-06 |
KR20010043973A (en) | 2001-05-25 |
BG104938A (en) | 2001-06-29 |
NO20006138D0 (en) | 2000-12-01 |
DE19824922A1 (en) | 1999-12-09 |
WO1999062882A1 (en) | 1999-12-09 |
AU764782B2 (en) | 2003-08-28 |
EA200100001A1 (en) | 2001-08-27 |
PL344467A1 (en) | 2001-11-05 |
HUP0102210A3 (en) | 2002-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5050294A1 (en) | NEW INDOLINONES REPLACED, THEIR PREPARATION AND THEIR EMPLOYMENT AS MEDICINES | |
CO5580788A2 (en) | BENCIMIDAZOL COMPOUNDS REPLACED USEFUL AS PROTEIN CINASE INHIBITORS | |
AR013199A1 (en) | SULFONAMIDES COMPOUND, PROCEDURE FOR ITS PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT | |
AR059778A1 (en) | PIRROLOTRIAZINE COMPOUNDS INHIBITORS OF P38 KINASES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USES IN GREAT VARIETY OF INFLAMMATORY PROCESSES. | |
AR055071A1 (en) | PIRROLO DERIVATIVES (3,2 - B) PYRIMIDINE. PHARMACEUTICAL COMPOSITIONS. | |
BR0208309A (en) | Arylisoxazoline derivatives, processes for their preparation and their application as pesticides | |
DE60315265D1 (en) | NITROGENIC HETEROCYCLIC COMPOUND AND MEDICINES THEREOF | |
AR041027A1 (en) | 1,2,3-TRIAZOL DERIVATIVES WITH PARTICULARLY FUNGICIATED ANTIMICROBIAL ACTIVITY | |
AR052177A1 (en) | MEDICATIONS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES | |
CY1112006T1 (en) | MACROCYCLIC INHIBITORS OF USITIS C virus | |
AR074902A1 (en) | DERIVATIVES OF 1,2,4-OXADIAZOLS AGONISTS OF RECEIVERS S1P1 | |
AR057357A1 (en) | HITEROCICLES NITROGENATED AS INHIBITORS OF HETEROARIL 11-BETA HYDROXIESTEROID DEHYDROGENASE TYPE 1. PHARMACEUTICAL COMPOSITIONS | |
AR041250A1 (en) | SULFONAMIDE DERIVATIVES AS INHIBITORS OF TNF-ALFA CONVERTER ENZYMES | |
PE20090042A1 (en) | CYCLOPAMINE ANALOGS | |
CO5611110A2 (en) | GLUCOCORTICOID MIMETICS, PROCEDURES FOR THE PREPARATION, PHARMACEUTICAL COMPOSITIONS AND USES OF THE SAME | |
CO5070570A1 (en) | THYROSINE DERIVATIVES AS ACTIVATORS OF hPPAR AND hPPARALFA AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM | |
AR069919A1 (en) | BIS- (SULFONYLAMINE) DERIVATIVES USEFUL FOR PAIN TREATMENT | |
BRPI0211844B8 (en) | compound of phenoxy-acetic acid or one of its pharmaceutically acceptable salts, and, pharmaceutical composition | |
AR035417A1 (en) | TRICYCLE DERIVATIVES OF LACTAMA AND SULTAMA, PROCESSES FOR THEIR DEVELOPMENT, DRUGS THAT CONTAIN THEM, AND THE USE OF SUCH COMPOUNDS IN THE PREPARATION OF DRUGS | |
EA200970379A1 (en) | BICYCLIC HETEROAROMATIC COMPOUNDS | |
CO5690577A2 (en) | IMIDAZOQUINOLINE DERIVATIVES AS ADENOSINE A3 RECEIVING LIGANDS | |
CO5031250A1 (en) | PHARMACEUTICAL COMPOUND | |
CO5690593A2 (en) | NEW DERIVATIVES OF PIRIMIDIN 2-AMINA | |
DE602007004740D1 (en) | ANTIBIOTIC SPIRO DERIVATIVES | |
AR060438A1 (en) | 2- (PIRIDIN-2-IL) - PYRIMIDINS AS FUNGICIDES. |